Skip to content
Clinical Trials – home
Research siteResponsive

Centrum Medyczne Omedica Jaroslaw Opiela I Beata Opiela Sp. j.

Poland Ul. Steszewska 41/4, 60-111 Poznan, Poland

  • 3 trials recruiting
  • Cardiovascular disorder · Hypertension · Obesity
  • Adult patients

About Specializations

Centrum Medyczne Omedica Jaroslaw Opiela I Beata Opiela Sp. j. in Poznan, Poland specialises in clinical trials of conditions such as Cardiovascular disorder, Hypertension, Obesity, Arteriosclerosis, and other specialisations. This site conducts important research.

Main research areas of the site

Cardiovascular Diseases

At Centrum Medyczne Omedica Jaroslaw Opiela I Beata Opiela Sp. j. in Poznan, clinical research in cardiovascular disease focuses on helping people with established atherosclerotic heart disease, high cardiovascular risk, and hypertension. These studies are designed to test new treatment approaches and better understand how to lower the chance of serious heart and blood vessel complications.

  • Preventing major cardiovascular events such as heart attack, stroke, and cardiovascular death
  • Reducing the risk of heart failure in people with elevated cardiovascular risk
  • Improving blood pressure control in patients whose hypertension is not well managed

The site’s work in this area reflects a strong interest in cardiovascular risk reduction and in evaluating therapies that may improve long-term outcomes for patients with chronic heart and vessel disease.

Nutritional and Metabolic Diseases

Research in nutritional and metabolic diseases at this site includes studies involving obesity, overweight, and type 2 diabetes mellitus. The trials are aimed at assessing whether new treatment options can improve weight management, support metabolic health, and lower the risk of diabetes-related complications.

  • Evaluating therapies for weight reduction in people with obesity or overweight
  • Studying treatment effects in participants with type 2 diabetes and cardiovascular risk
  • Exploring whether metabolic treatments can also help reduce major cardiovascular events

This research area combines metabolic care and cardiovascular prevention, showing a focus on therapies that may benefit both body weight and long-term heart health.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Site location
Ul. Steszewska 41/460-111 PoznanPoland
Recruiting now
3 trials
Conditions studied
4

More sites in PoznanPoland

Recruiting now

Ongoing trials

Clinical trials currently enrolling participants at this site.

Condition
Type of trial
Recruitment status
Quick filters

4 clinical trials

Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:ZILEBESIRAN
  • Sponsor:Alnylam Pharmaceuticals Inc.
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Baxdrostat
  • Sponsor:AstraZeneca AB
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Obicetrapib
  • Sponsor:NewAmsterdam Pharma B.V.
Is this your site?

Join our network of research sites

Get verified: confirm your contact details and recruitment status with us, appear first on the pages of your trials and receive patient requests directly.

See the offer for sites
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.